Merck & Co., Inc. (NYSE: MRK) announced today that the U.S. FDA has issued a second complete response letter regarding ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE